Literature DB >> 21576245

Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).

Rithwik Ramachandran1, Koichiro Mihara, Hyunjae Chung, Bernard Renaux, Chang S Lau, Daniel A Muruve, Kathryn A DeFea, Michel Bouvier, Morley D Hollenberg.   

Abstract

Human neutrophil proteinases (elastase, proteinase-3, and cathepsin-G) are released at sites of acute inflammation. We hypothesized that these inflammation-associated proteinases can affect cell signaling by targeting proteinase-activated receptor-2 (PAR(2)). The PAR family of G protein-coupled receptors is triggered by a unique mechanism involving the proteolytic unmasking of an N-terminal self-activating tethered ligand (TL). Proteinases can either activate PAR signaling by unmasking the TL sequence or disarm the receptor for subsequent enzyme activation by cleaving downstream from the TL sequence. We found that none of neutrophil elastase, cathepsin-G, and proteinase-3 can activate G(q)-coupled PAR(2) calcium signaling; but all of these proteinases can disarm PAR(2), releasing the N-terminal TL sequence, thereby preventing G(q)-coupled PAR(2) signaling by trypsin. Interestingly, elastase (but neither cathepsin-G nor proteinase-3) causes a TL-independent PAR(2)-mediated activation of MAPK that, unlike the canonical trypsin activation, does not involve either receptor internalization or recruitment of β-arrestin. Cleavage of synthetic peptides derived from the extracellular N terminus of PAR(2), downstream of the TL sequence, demonstrated distinct proteolytic sites for all three neutrophil-derived enzymes. We conclude that in inflammation, neutrophil proteinases can modulate PAR(2) signaling by preventing/disarming the G(q)/calcium signal pathway and, via elastase, can selectively activate the p44/42 MAPK pathway. Our data illustrate a new mode of PAR regulation that involves biased PAR(2) signaling by neutrophil elastase and a disarming/silencing effect of cathepsin-G and proteinase-3.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576245      PMCID: PMC3137039          DOI: 10.1074/jbc.M110.201988

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  International Union of Pharmacology. XXVIII. Proteinase-activated receptors.

Authors:  Morley D Hollenberg; Steven J Compton
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

2.  Cathepsin G activates protease-activated receptor-4 in human platelets.

Authors:  G R Sambrano; W Huang; T Faruqi; S Mahrus; C Craik; S R Coughlin
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

4.  cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization.

Authors:  U B Rasmussen; V Vouret-Craviari; S Jallat; Y Schlesinger; G Pagès; A Pavirani; J P Lecocq; J Pouysségur; E Van Obberghen-Schilling
Journal:  FEBS Lett       Date:  1991-08-19       Impact factor: 4.124

Review 5.  Structure, function and pathophysiology of protease activated receptors.

Authors:  Mark N Adams; Rithwik Ramachandran; Mei-Kwan Yau; Jacky Y Suen; David P Fairlie; Morley D Hollenberg; John D Hooper
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

6.  Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis.

Authors:  S Fiorucci; A Mencarelli; B Palazzetti; E Distrutti; N Vergnolle; M D Hollenberg; J L Wallace; A Morelli; G Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

7.  Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.

Authors:  D Loew; C Perrault; M Morales; S Moog; C Ravanat; S Schuhler; R Arcone; C Pietropaolo; J P Cazenave; A van Dorsselaer; F Lanza
Journal:  Biochemistry       Date:  2000-09-05       Impact factor: 3.162

8.  Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases.

Authors:  Sophie Dulon; Céline Candé; Nigel W Bunnett; Morley D Hollenberg; Michel Chignard; Dominique Pidard
Journal:  Am J Respir Cell Mol Biol       Date:  2003-03       Impact factor: 6.914

9.  Proteinase-activated receptor-2: key role of amino-terminal dipeptide residues of the tethered ligand for receptor activation.

Authors:  Bahjat Al-Ani; Kristina K Hansen; Morley D Hollenberg
Journal:  Mol Pharmacol       Date:  2004-01       Impact factor: 4.436

10.  The proteinase-activated receptor-2 mediates phagocytosis in a Rho-dependent manner in human keratinocytes.

Authors:  Glynis Scott; Sonya Leopardi; Lorelle Parker; Laura Babiarz; Miri Seiberg; Rujiing Han
Journal:  J Invest Dermatol       Date:  2003-09       Impact factor: 8.551

View more
  64 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration.

Authors:  Aurélie Borrull; Bertrand Allard; Anne Wijkhuisen; Amaury Herbet; Patricia Lamourette; Wided Birouk; Denis Leiber; Zahra Tanfin; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud; Philippe Robin
Journal:  MAbs       Date:  2016-07-08       Impact factor: 5.857

3.  Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.

Authors:  Peishen Zhao; TinaMarie Lieu; Nicholas Barlow; Silvia Sostegni; Silke Haerteis; Christoph Korbmacher; Wolfgang Liedtke; Nestor N Jimenez-Vargas; Stephen J Vanner; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

Review 4.  Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.

Authors:  M D Hollenberg; K Mihara; D Polley; J Y Suen; A Han; D P Fairlie; R Ramachandran
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

5.  Protease-Mediated Suppression of DRG Neuron Excitability by Commensal Bacteria.

Authors:  Jessica L Sessenwein; Corey C Baker; Sabindra Pradhananga; Megan E Maitland; Elaine O Petrof; Emma Allen-Vercoe; Curtis Noordhof; David E Reed; Stephen J Vanner; Alan E Lomax
Journal:  J Neurosci       Date:  2017-10-31       Impact factor: 6.167

6.  Elastase induces lung epithelial cell autophagy through placental growth factor: a new insight of emphysema pathogenesis.

Authors:  Hsin-Han Hou; Shih-Lung Cheng; Kuei-Pin Chung; Mark Yen-Ping Kuo; Cheng-Chang Yeh; Bei-En Chang; Hsuan-Hsuan Lu; Hao-Chien Wang; Chong-Jen Yu
Journal:  Autophagy       Date:  2014-06-25       Impact factor: 16.016

Review 7.  Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection.

Authors:  M D Hollenberg
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

8.  Cockroach allergen serine proteinases: Isolation, sequencing and signalling via proteinase-activated receptor-2.

Authors:  D J Polley; K Mihara; R Ramachandran; H Vliagoftis; B Renaux; M Saifeddine; M O Daines; S Boitano; M D Hollenberg
Journal:  Clin Exp Allergy       Date:  2017-04-27       Impact factor: 5.018

Review 9.  Role of the blood coagulation cascade in hepatic fibrosis.

Authors:  Asmita Pant; Anna K Kopec; James P Luyendyk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-03       Impact factor: 4.052

10.  Polarization of protease-activated receptor 2 (PAR-2) signaling is altered during airway epithelial remodeling and deciliation.

Authors:  Ryan M Carey; Jenna R Freund; Benjamin M Hariri; Nithin D Adappa; James N Palmer; Robert J Lee
Journal:  J Biol Chem       Date:  2020-04-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.